-
Mashup Score: 1Why Do We Anthropomorphize Corporations? - 3 month(s) ago
Similar to people, we see companies as having personalities.
Source: www.psychologytoday.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 35
Original Article from The New England Journal of Medicine — Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Patient With IgG Heavy Chain Disease Presents With Parathyroid Hormone-Related Peptide Mediated Hypercalcemia - 6 month(s) ago
Multiple myeloma is associated with excessive tumor-induced, osteoclast-mediated bone destruction. Hypercalcemia remains the most frequent metabolic c…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Safety and Efficacy of Traditional Heart Failure Therapies in Patients With Cardiac Amyloidosis and Heart Failure - 9 month(s) ago
Randomized controlled trials have demonstrated mortality benefits for several medication classes in patients with heart failure (HF), especially with …
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Scientists concerned about ‘unheard of’ conditions off the coast of England: ‘We could see mass mortality’ - 10 month(s) ago
“It will go unnoticed.”
Source: Yahoo NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Myeloma Rounds South Florida | Leukemia and Lymphoma Society - 11 month(s) ago
Format New Live, In-Person Event *Pre-registration required Live interactive continuing medical education activity for healthcare professionals in South Florida to discuss multiple myeloma updates and challenges in treatment. Target Audience This activity is intended for hematologists-oncologists, medical oncologists, nurse practitioners, nurses and pharmacists involved in the care of patients…
Source: www.lls.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
The net impact of malignancy and anti-tumor therapy on bone resorption in myeloma is poorly understood because conventional skeletal radiographs are relatively insensitive for the diagnosis and mon…
Source: Taylor & FrancisCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Benefits of Virtual Conference Attendance: ASH 2022 Edition - 1 year(s) ago
The 64th ASH Annual Meeting and Exposition took place recently from December 10th through 13th in New Orleans, Louisiana. Like 2021, this year’s co…
Source: opmed.doximity.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3
The treatment of relapse or refractory multiple myeloma (RRMM) is still a big challenge in clinic. Recently, several clinical trials indicated that th…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
@AaronGoodman33 @VPrasadMDMPH @DavidSteensma Has it really been a group? I’ve seen it promoted as “possible” occ- or to “consider” particularly for del17p- but haven’t seen anyone really push that- Regardless- hoping we get some better predictive biomarkers- thought this was interesting - https://t.co/GPYR856ykF
-
-
Mashup Score: 4Systemic Immunoglobulin Light Chain Amyloidosis Presenting as Painful Penile Ulcers | Annals of Internal Medicine: Clinical Cases - 2 year(s) ago
Immunoglobulin light chain (AL) amyloidosis is a systemic form of amyloidosis that commonly affects the heart, kidney, liver, and nervous system. Penile involvement in AL amyloidosis is rare and thus often not considered in the differential diagnosis for penile ulcers. We report a case of an elderly man with nonhealing, painful penile ulcers who had AL amyloidosis with cardiac, renal, and liver…
Categories: Hem/Oncs, Latest HeadlinesTweet
@AaronGoodman33 @ManniMD1 @bmsnews I think ur attributing intention and evil to a corporation. “They” are about profit which is what capitalist structure demands them to be. It’s up to outside forces to regulate corporate behavior. Given the stakes of the health industry, more is needed. https://t.co/ZMW2grQGKm